Is Big Pharma Ignoring Small Biotech?

<p>Recent news might have you believe Big Pharma is turning its back on innovation hubs like small-cap biotech companies. Headlines scream about &ldquo;dying deals&rdquo; and a &ldquo;broken acquisition market,&rdquo; depicting a pharma giant spurning the next blockbuster cure. While sales potential undoubtedly influences biotech companies&rsquo; acquisition, it&rsquo;s not the only criterion.</p> <p>Here&rsquo;s why the &ldquo;Big Pharma vs. Small Biotech&rdquo; narrative might be missing the mark:</p> <p><a href="https://richardameyer.medium.com/is-big-pharma-ignoring-small-biotech-721e102d84de"><strong>Website</strong></a></p>